Tatiana Aragão Figueiredo

[Selection of essential medicines and the burden of disease in Brazil.]

J. Schramm, V. Pepe, Tatiana Aragão Figueiredo, 2014, Cadernos de saude publica.

Rational therapeutics: health-related elements in lawsuits demanding medicines.

C. Osorio-de-Castro, Miriam Ventura, V. Pepe, 2011, Revista de saude publica.

The public production of medicines compared to the National Policy of Medicines and the burden of disease in Brazil.

J. Schramm, V. Pepe, Tatiana Aragão Figueiredo, 2017, Cadernos de saude publica.

[Characterization of lawsuits for the supply of "essential" medicines in the State of Rio de Janeiro, Brazil].

C. Osorio-de-Castro, V. Pepe, Tatiana Aragão Figueiredo, 2010, Cadernos de saude publica.

Evidence-based process for decision-making in the analysis of legal demands for medicines in Brazil.

C. Osorio-de-Castro, V. Pepe, Tatiana Aragão Figueiredo, 2013, Cadernos de saude publica.

[The scientific production and research groups on sanitary surveillance at CNPq].

V. Pepe, Tatiana Aragão Figueiredo, Catia Verônica dos Santos Oliveira, 2010, Ciência & Saúde Coletiva.

The public production of medicines in Brazil A produção pública de medicamentos no Brasil

Tatiana Aragão Figueiredo, 2021 .

[The Brazilian market for monoclonal antibodies used in cancer treatment].

V. Pepe, Tatiana Aragão Figueiredo, Thaís Jeronimo Vidal, 2018, Cadernos de saude publica.

The public production of medicines in Brazil.

Tatiana Aragão Figueiredo, Renato Gonçalves Fialho Neto, Jorge Lima de Magalhães, 2021, Ciencia & saude coletiva.